Literature DB >> 25534448

Serine protease inhibitor-6 differentially affects the survival of effector and memory alloreactive CD8-T cells.

J Azzi1, S Ohori, C Ting, M Uehara, R Abdoli, B D Smith, K Safa, Z Solhjou, P Lukyanchykov, J Patel, M McGrath, R Abdi.   

Abstract

The clonal expansion of effector T cells and subsequent generation of memory T cells are critical in determining the outcome of transplantation. While cytotoxic T lymphocytes induce direct cytolysis of target cells through secretion of Granzyme-B (GrB), they also express cytoplasmic serine protease inhibitor-6 (Spi6) to protect themselves from GrB that has leaked from granules. Here, we studied the role of GrB/Spi6 axis in determining clonal expansion of alloreactive CD8-T cells and subsequent generation of memory CD8-T cells in transplantation. CD8-T cells from Spi6(-/-) mice underwent more GrB mediated apoptosis upon alloantigen stimulation in vitro and in vivo following adoptive transfer into an allogeneic host. Interestingly, while OT1.Spi6(-/-) CD8 T cells showed significantly lower clonal expansion following skin transplants from OVA mice, there was no difference in the size of the effector memory CD8-T cells long after transplantation. Furthermore, lack of Spi6 resulted in a decrease of short-lived-effector-CD8-cells but did not impact the pool of memory-precursor-effector-CD8-cells. Similar results were found in heart transplant models. Our findings suggest that the final alloreactive CD8-memory-pool-size is independent from the initial clonal-proliferation as memory precursors express low levels of GrB and therefore are independent of Spi6 for survival. These data advance our understanding of memory T cells generation in transplantation and provide basis for Spi6 based strategies to target effector T cells. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Basic (laboratory) research/science; T cell biology; immunobiology; organ transplantation in general; rejection: T cell-mediated (TCMR)

Mesh:

Substances:

Year:  2015        PMID: 25534448      PMCID: PMC4976694          DOI: 10.1111/ajt.13051

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  30 in total

1.  CD4(+) T cell effectors can become memory cells with high efficiency and without further division.

Authors:  H Hu; G Huston; D Duso; N Lepak; E Roman; S L Swain
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 2.  Memory T cells: a hurdle to immunologic tolerance.

Authors:  Fadi G Lakkis; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

Review 3.  Shaping and reshaping CD8+ T-cell memory.

Authors:  John T Harty; Vladimir P Badovinac
Journal:  Nat Rev Immunol       Date:  2008-02       Impact factor: 53.106

4.  Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.

Authors:  David C Gondek; Victor Devries; Elizabeth C Nowak; Li-Fan Lu; Kathryn A Bennett; Zachary A Scott; Randolph J Noelle
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 5.  Developing and maintaining protective CD8+ memory T cells.

Authors:  Matthew A Williams; Brittany J Holmes; Joseph C Sun; Michael J Bevan
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

6.  Lesions of T-cell-mediated kidney allograft rejection in mice do not require perforin or granzymes A and B.

Authors:  Philip F Halloran; Joan Urmson; Vido Ramassar; Anette Melk; Lin-Fu Zhu; Brendan P Halloran; R Chris Bleackley
Journal:  Am J Transplant       Date:  2004-05       Impact factor: 8.086

7.  The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.

Authors:  Claire E Hirst; Marguerite S Buzza; Catherina H Bird; Hilary S Warren; Paul U Cameron; Manling Zhang; Philip G Ashton-Rickardt; Phillip I Bird
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

8.  The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses.

Authors:  D Kägi; P Seiler; J Pavlovic; B Ledermann; K Bürki; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

9.  Virus-specific CD8+ T-cell memory determined by clonal burst size.

Authors:  S Hou; L Hyland; K W Ryan; A Portner; P C Doherty
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

10.  Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts.

Authors:  Jonathan C Choy; Alexandra Kerjner; Brian W Wong; Bruce M McManus; David J Granville
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more
  6 in total

1.  Testing the Efficacy of Contrast-Enhanced Ultrasound in Detecting Transplant Rejection Using a Murine Model of Heart Transplantation.

Authors:  K Fischer; S Ohori; F C Meral; M Uehara; S Giannini; T Ichimura; R N Smith; F A Jolesz; I Guleria; Y Zhang; P J White; N J McDannold; K Hoffmeister; M M Givertz; R Abdi
Journal:  Am J Transplant       Date:  2017-02-01       Impact factor: 8.086

2.  Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect.

Authors:  Wei Du; Hemn Mohammadpour; Rachel E O'Neill; Sandeep Kumar; Chuan Chen; Michelle Qiu; Lin Mei; Jingxin Qiu; Philip L McCarthy; Kelvin P Lee; Xuefang Cao
Journal:  Oncoimmunology       Date:  2017-11-16       Impact factor: 8.110

3.  Host-Derived Serine Protease Inhibitor 6 Provides Granzyme B-Independent Protection of Intestinal Epithelial Cells in Murine Graft-versus-Host Disease.

Authors:  Hemn Mohammadpour; Wei Du; Rachel O'Neill; Saeed Khalili; Jingxin Qiu; Elizabeth A Repasky; Philip L McCarthy; Xuefang Cao
Journal:  Biol Blood Marrow Transplant       Date:  2018-07-10       Impact factor: 5.742

Review 4.  Human Granzyme B Based Targeted Cytolytic Fusion Proteins.

Authors:  Precious Hlongwane; Neelakshi Mungra; Suresh Madheswaran; Olusiji A Akinrinmade; Shivan Chetty; Stefan Barth
Journal:  Biomedicines       Date:  2018-06-20

5.  Targeted Delivery of Immunomodulators to Lymph Nodes.

Authors:  Jamil Azzi; Qian Yin; Mayuko Uehara; Shunsuke Ohori; Li Tang; Kaimin Cai; Takaharu Ichimura; Martina McGrath; Omar Maarouf; Eirini Kefaloyianni; Scott Loughhead; Jarolim Petr; Qidi Sun; Mincheol Kwon; Stefan Tullius; Ulrich H von Andrian; Jianjun Cheng; Reza Abdi
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423

6.  Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.

Authors:  F S Peters; A M A Peeters; T P P van den Bosch; A L Mooyaart; J van de Wetering; M G H Betjes; C C Baan; K Boer
Journal:  Clin Exp Immunol       Date:  2019-05-30       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.